Latest news
MEDIA RELEASE: Oct 03, 2022 01:07 PM
New epigenetic markers for prostate cancer discovered
The discovery of a new biomarker for prostate cancer could lead to better diagnosis and treatment for men with the aggressive form of this disease.
MEDIA RELEASE: Dec 03, 2018 09:22 AM
Blood test could predict if chemotherapy will work for advan...
World-first trial by Australian researchers
Mar 11, 2018 10:00 AM
Major funding boost for prostate cancer in NSW
A new $3.75 million collaborative project aims to accelerate personalised approaches to prostate cancer treatment – and is part of a total package of $12 million awarded to cancer researchers at Garvan and across NSW.
Jan 22, 2018 09:00 PM
Key support for Garvan’s cancer research in 2018 and beyond
Garvan researchers are thrilled to be among the recipients of grants in recently announced funding schemes from the National Breast Cancer Foundation and Cancer Australia. The funding will provide crucial support for a n...
Nov 23, 2017 09:37 AM
Small but mighty: the tiny molecules that regulate cancer ce...
A Garvan-led research team has performed the largest ever study of how ‘microRNAs’ function in cancer cells. Hundreds of these tiny molecules play an important role in whether cancer cells live or die, the researchers fo...
Nov 16, 2017 03:13 PM
How genes drive prostate cancer: all in the packaging?
Garvan researchers have shown that a unique protein, H2A.Z, which packages DNA in cells, may drive the progression of prostate cancer. When it becomes chemically ‘tagged,’ H2A.Z uncoils and re-organises the DNA in cancer...